Media Coverage

Tranzyme Pharma Inc. Interview by Wall Street Reporter

Wall Street Reporter (November 1, 2007)

Gastrointestinal drugs focus of local company

The Herald Sun (August 8, 2005)

Once Neglected, Gastrointestinal Diseases Begin to Draw Biotech Investors

Venture Capital Analyst (July 2005)

Tranzyme’s Story: Early Stage Firm Brings in $32M Financing

BioWorld Today (May 13, 2005)

Tranzyme Closes $32M in Oversubscribed Series B Round

VentureWire Professional (May 13, 2005)

VentureReporter Weekly

Venture Reporter Weekly (May 13, 2005)

Tranzyme Takes the Merger Plunge

Bioventure View (January 13, 2004)

Tranzyme and Neokimia Merge

Genetic Engineering News (December 19, 2003)

Tranzyme and Neokimia to Focus on Drug Discovery and Development

Canadian Biotech News (December 15, 2003)